Related Experiment Video
Updated: Mar 2, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation
Sarah A Low1, Wendye Robbins2,3, Vivianne L Tawfik2
1Department of Internal Medicine, Banner University Medical Center, University of Arizona College of Medicine, Tucson, AZ.
Abstract:
A 41-year-old woman presented with burning and erythema in her extremities triggered by warmth and activity, which was relieved by applying ice. Extensive workup was consistent with adult-onset primary erythromelalgia (EM). Several pharmacological treatments were tried including local anesthetics, capsaicin, ziconotide, and dantrolene, all providing 24-48 hours of relief followed by symptom flare. Interventional therapies, including peripheral and sympathetic ganglion blocks, also failed. Thus far, clonidine and ketamine have been the only effective agents for our patient. Genetic testing was negative for an EM-associated mutation in the SCN9A gene, encoding the NaV1.7 sodium channel, suggesting a mutation in an alternate gene.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Angina IV: Management